$111.53
-1.58-1.40%
At Close: -
$111.53
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Visteon
VCNASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Visteon (NASDAQ:VC) Stock, Analyst Ratings, Price Targets, Forecasts
Visteon Corp has a consensus price target of $136.77 based on the ratings of 24 analysts. The high is $180 issued by B of A Securities on September 26, 2023. The low is $75 issued by Morgan Stanley on July 30, 2021. The 3 most-recent analyst ratings were released by TD Cowen, Wells Fargo, and JP Morgan on July 26, 2024, July 26, 2024, and July 22, 2024, respectively. With an average price target of $130 between TD Cowen, Wells Fargo, and JP Morgan, there's an implied 16.56% upside for Visteon Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
TD Cowen
Wells Fargo
JP Morgan
Citigroup
Baird
1calculated from analyst ratings
Analyst Ratings for Visteon
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/26/2024 | Buy Now | 25.53% | TD Cowen | Jeffrey Osborne | $142 → $140 | Maintains | Buy | Get Alert |
| 07/26/2024 | Buy Now | 3.11% | Wells Fargo | Colin Langan | $107 → $115 | Maintains | Equal-Weight | Get Alert |
| 07/22/2024 | Buy Now | 21.04% | JP Morgan | Ryan Brinkman | $144 → $135 | Maintains | Neutral | Get Alert |
| 07/12/2024 | Buy Now | 12.97% | Citigroup | Itay Michaeli | $139 → $126 | Maintains | Buy | Get Alert |
| 07/12/2024 | Buy Now | 7.59% | Baird | Luke Junk | $137 → $120 | Downgrade | Outperform → Neutral | Get Alert |
| 07/10/2024 | Buy Now | 19.25% | Goldman Sachs | Mark Delaney | $161 → $133 | Maintains | Buy | Get Alert |
| 07/10/2024 | Buy Now | 21.04% | UBS | Joseph Spak | $144 → $135 | Maintains | Buy | Get Alert |
| 06/25/2024 | Buy Now | -4.06% | Wells Fargo | Colin Langan | $108 → $107 | Maintains | Equal-Weight | Get Alert |
| 05/10/2024 | Buy Now | 21.04% | Morgan Stanley | Adam Jonas | $145 → $135 | Maintains | Equal-Weight | Get Alert |
| 04/26/2024 | Buy Now | 22.84% | Baird | Luke Junk | $140 → $137 | Maintains | Outperform | Get Alert |
| 04/26/2024 | Buy Now | -3.17% | Wells Fargo | Colin Langan | → $108 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 04/22/2024 | Buy Now | 30.01% | JP Morgan | Ryan Brinkman | $146 → $145 | Maintains | Neutral | Get Alert |
| 04/17/2024 | Buy Now | 12.97% | Guggenheim | Ronald Jewsikow | $136 → $126 | Maintains | Buy | Get Alert |
| 04/10/2024 | Buy Now | 30.01% | Barclays | Dan Levy | $140 → $145 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 03/07/2024 | Buy Now | 30.91% | RBC Capital | Tom Narayan | $188 → $146 | Maintains | Outperform | Get Alert |
| 02/29/2024 | Buy Now | 43.46% | B of A Securities | John Murphy | $165 → $160 | Maintains | Buy | Get Alert |
| 02/21/2024 | Buy Now | -4.96% | Wells Fargo | Colin Langan | $101 → $106 | Maintains | Underweight | Get Alert |
| 01/25/2024 | Buy Now | 32.7% | JP Morgan | Ryan Brinkman | $160 → $148 | Maintains | Neutral | Get Alert |
| 01/24/2024 | Buy Now | 25.53% | Barclays | Raimo Lenschow | $158 → $140 | Maintains | Equal-Weight | Get Alert |
| 01/17/2024 | Buy Now | 30.01% | UBS | Joseph Spak | $143 → $145 | Upgrade | Neutral → Buy | Get Alert |
| 01/11/2024 | Buy Now | 67.67% | RBC Capital | Tom Narayan | → $187 | Reiterates | Outperform → Outperform | Get Alert |
| 01/04/2024 | Buy Now | — | Wolfe Research | Shreyas Patil | — | Downgrade | Outperform → Peer Perform | Get Alert |
| 12/13/2023 | Buy Now | 16.56% | Exane BNP Paribas | James Picariello | → $130 | Downgrade | Outperform → Neutral | Get Alert |
| 11/06/2023 | Buy Now | 33.6% | Citigroup | Itay Michaeli | → $149 | Upgrade | Neutral → Buy | Get Alert |
| 10/27/2023 | Buy Now | 28.22% | UBS | Colin Langan | $146 → $143 | Maintains | Neutral | Get Alert |
| 10/12/2023 | Buy Now | — | Barclays | Raimo Lenschow | — | Upgrade | Underweight → Equal-Weight | Get Alert |
| 10/11/2023 | Buy Now | 33.6% | Citigroup | Itay Michaeli | $160 → $149 | Maintains | Neutral | Get Alert |
| 10/03/2023 | Buy Now | 10.28% | Wells Fargo | Colin Langan | $138 → $123 | Maintains | Underweight | Get Alert |
| 09/26/2023 | Buy Now | 61.39% | B of A Securities | John Babcock | → $180 | Reinstates | → Buy | Get Alert |
| 09/13/2023 | Buy Now | 40.77% | UBS | Colin Langan | → $157 | Initiates | → Neutral | Get Alert |
| 08/07/2023 | Buy Now | 21.04% | Barclays | Raimo Lenschow | $130 → $135 | Maintains | Underweight | Get Alert |
| 08/04/2023 | Buy Now | 63.18% | RBC Capital | Tom Narayan | $184 → $182 | Maintains | Outperform | Get Alert |
| 08/04/2023 | Buy Now | 23.73% | Wells Fargo | Colin Langan | $130 → $138 | Maintains | Underweight | Get Alert |
| 07/20/2023 | Buy Now | 40.77% | JP Morgan | Ryan Brinkman | $156 → $157 | Maintains | Neutral | Get Alert |
| 07/18/2023 | Buy Now | 43.46% | Citigroup | Itay Michaeli | $159 → $160 | Maintains | Neutral | Get Alert |
| 07/10/2023 | Buy Now | 16.56% | Wells Fargo | Colin Langan | $127 → $130 | Maintains | Underweight | Get Alert |
| 06/08/2023 | Buy Now | 56.91% | Wolfe Research | Shreyas Patil | → $175 | Upgrade | Peer Perform → Outperform | Get Alert |
| 05/17/2023 | Buy Now | 44.36% | Guggenheim | Ronald Jewsikow | → $161 | Upgrade | Neutral → Buy | Get Alert |
| 05/01/2023 | Buy Now | 42.56% | Citigroup | Itay Michaeli | $165 → $159 | Maintains | Neutral | Get Alert |
| 04/28/2023 | Buy Now | 13.87% | Wells Fargo | Colin Langan | $126 → $127 | Maintains | Underweight | Get Alert |
| 04/17/2023 | Buy Now | 16.56% | Barclays | Raimo Lenschow | $135 → $130 | Maintains | Underweight | Get Alert |
| 04/10/2023 | Buy Now | 12.97% | Wells Fargo | Colin Langan | $125 → $126 | Maintains | Underweight | Get Alert |
| 03/14/2023 | Buy Now | 47.94% | Citigroup | Itay Michaeli | $145 → $165 | Maintains | Neutral | Get Alert |
| 03/09/2023 | Buy Now | 30.01% | Morgan Stanley | Adam Jonas | $135 → $145 | Maintains | Equal-Weight | Get Alert |
| 03/08/2023 | Buy Now | 64.98% | RBC Capital | Tom Narayan | $169 → $184 | Maintains | Outperform | Get Alert |
| 02/21/2023 | Buy Now | 21.04% | Morgan Stanley | Adam Jonas | $115 → $135 | Maintains | Equal-Weight | Get Alert |
| 02/17/2023 | Buy Now | 12.08% | Wells Fargo | Colin Langan | $102 → $125 | Maintains | Underweight | Get Alert |
| 02/17/2023 | Buy Now | 61.39% | Goldman Sachs | Mark Delaney | $160 → $180 | Maintains | Buy | Get Alert |
| 02/17/2023 | Buy Now | 52.43% | Baird | Luke Junk | $163 → $170 | Maintains | Outperform | Get Alert |
| 02/17/2023 | Buy Now | — | Guggenheim | Ali Faghri | — | Downgrade | Buy → Neutral | Get Alert |
| 02/15/2023 | Buy Now | 12.08% | Barclays | Dan Levy | → $125 | Initiates | → Underweight | Get Alert |
| 01/17/2023 | Buy Now | -8.54% | Wells Fargo | Colin Langan | $101 → $102 | Maintains | Underweight | Get Alert |
| 01/13/2023 | Buy Now | 30.01% | Citigroup | Itay Michaeli | $129 → $145 | Maintains | Neutral | Get Alert |
| 10/28/2022 | Buy Now | 3.11% | Morgan Stanley | Adam Jonas | $107 → $115 | Maintains | Equal-Weight | Get Alert |
| 10/28/2022 | Buy Now | 44.36% | RBC Capital | Joseph Spak | $153 → $161 | Maintains | Outperform | Get Alert |
| 10/28/2022 | Buy Now | -6.75% | Wells Fargo | Colin Langan | $103 → $104 | Maintains | Underweight | Get Alert |
| 10/24/2022 | Buy Now | 15.66% | JP Morgan | Ryan Brinkman | → $129 | Upgrade | Underweight → Neutral | Get Alert |
| 09/28/2022 | Buy Now | 6.7% | Citigroup | Itay Michaeli | $128 → $119 | Maintains | Neutral | Get Alert |
| 09/28/2022 | Buy Now | 36.29% | Berenberg | Jared Maymon | → $152 | Assumes | → Buy | Get Alert |
| 09/23/2022 | Buy Now | -7.65% | Wells Fargo | Colin Langan | $101 → $103 | Maintains | Underweight | Get Alert |
| 08/02/2022 | Buy Now | -4.06% | Morgan Stanley | Adam Jonas | $91 → $107 | Maintains | Equal-Weight | Get Alert |
| 08/02/2022 | Buy Now | 14.77% | Citigroup | Itay Michaeli | $115 → $128 | Maintains | Neutral | Get Alert |
| 07/14/2022 | Buy Now | -18.41% | Morgan Stanley | Adam Jonas | $93 → $91 | Maintains | Equal-Weight | Get Alert |
| 07/11/2022 | Buy Now | 19.25% | Exane BNP Paribas | James Picariello | → $133 | Upgrade | Neutral → Outperform | Get Alert |
| 07/11/2022 | Buy Now | -12.13% | Wells Fargo | Colin Langan | $88 → $98 | Maintains | Underweight | Get Alert |
| 06/01/2022 | Buy Now | -16.61% | Morgan Stanley | Adam Jonas | → $93 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 04/29/2022 | Buy Now | 33.6% | RBC Capital | Joseph Spak | $146 → $149 | Maintains | Outperform | Get Alert |
| 04/29/2022 | Buy Now | -21.1% | Wells Fargo | Colin Langan | $86 → $88 | Maintains | Underweight | Get Alert |
| 04/21/2022 | Buy Now | 13.87% | Deutsche Bank | Emmanuel Rosner | $150 → $127 | Maintains | Buy | Get Alert |
| 04/11/2022 | Buy Now | — | Exane BNP Paribas | James Picariello | — | Initiates | → Neutral | Get Alert |
| 04/07/2022 | Buy Now | 25.53% | Barclays | Brian Johnson | $145 → $140 | Maintains | Overweight | Get Alert |
| 04/06/2022 | Buy Now | -35.44% | Morgan Stanley | Adam Jonas | $75 → $72 | Maintains | Underweight | Get Alert |
| 04/06/2022 | Buy Now | 25.53% | B of A Securities | John Murphy | $122 → $140 | Upgrade | Underperform → Neutral | Get Alert |
| 04/01/2022 | Buy Now | -22.89% | Wells Fargo | Colin Langan | $91 → $86 | Maintains | Underweight | Get Alert |
| 03/22/2022 | Buy Now | 23.73% | Goldman Sachs | Mark Delaney | $156 → $138 | Maintains | Buy | Get Alert |
| 02/22/2022 | Buy Now | 39.87% | Goldman Sachs | Mark Delaney | $119 → $156 | Upgrade | Neutral → Buy | Get Alert |
| 02/18/2022 | Buy Now | 30.01% | Baird | Luke Junk | $140 → $145 | Maintains | Outperform | Get Alert |
| 02/18/2022 | Buy Now | 30.01% | Jefferies | David Kelley | $132 → $145 | Maintains | Buy | Get Alert |
| 10/29/2021 | Buy Now | -22.89% | Wells Fargo | Colin Langan | — | Maintains | Underweight | Get Alert |
| 10/29/2021 | Buy Now | 25.53% | Barclays | Brian Johnson | — | Upgrade | Equal-Weight → Overweight | Get Alert |
| 10/11/2021 | Buy Now | 2.21% | Barclays | Brian Johnson | — | Maintains | Equal-Weight | Get Alert |
| 10/05/2021 | Buy Now | -21.1% | Wells Fargo | Colin Langan | — | Maintains | Underweight | Get Alert |
| 09/27/2021 | Buy Now | -6.75% | Goldman Sachs | Mark Delaney | — | Maintains | Neutral | Get Alert |
| 09/20/2021 | Buy Now | 4.01% | Jefferies | David Kelley | — | Upgrade | Hold → Buy | Get Alert |
| 09/16/2021 | Buy Now | — | B of A Securities | John Murphy | — | Downgrade | Neutral → Underperform | Get Alert |
| 09/10/2021 | Buy Now | -9.44% | Wells Fargo | Colin Langan | — | Maintains | Underweight | Get Alert |
| 07/30/2021 | Buy Now | -32.75% | Morgan Stanley | — | — | Maintains | Underweight | Get Alert |
| 07/30/2021 | Buy Now | 26.42% | RBC Capital | Joseph Spak | — | Maintains | Outperform | Get Alert |
| 07/30/2021 | Buy Now | 25.53% | Deutsche Bank | Emmanuel Rosner | — | Maintains | Buy | Get Alert |
FAQ
What is the target price for Visteon (VC) stock?
The latest price target for Visteon (NASDAQ:VC) was reported by TD Cowen on July 26, 2024. The analyst firm set a price target for $140.00 expecting VC to rise to within 12 months (a possible 25.53% upside). 33 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Visteon (VC)?
The latest analyst rating for Visteon (NASDAQ:VC) was provided by TD Cowen, and Visteon maintained their buy rating.
When was the last upgrade for Visteon (VC)?
The last upgrade for Visteon Corp happened on April 26, 2024 when Wells Fargo raised their price target to $108. Wells Fargo previously had an underweight for Visteon Corp.
When was the last downgrade for Visteon (VC)?
The last downgrade for Visteon Corp happened on July 12, 2024 when Baird changed their price target from $137 to $120 for Visteon Corp.
When is the next analyst rating going to be posted or updated for Visteon (VC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Visteon, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Visteon was filed on July 26, 2024 so you should expect the next rating to be made available sometime around July 26, 2025.
Is the Analyst Rating Visteon (VC) correct?
While ratings are subjective and will change, the latest Visteon (VC) rating was a maintained with a price target of $142.00 to $140.00. The current price Visteon (VC) is trading at is $111.53, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.